Wegovy Faqs

Wegovy is approved by the FDA for people who fall into one of two categories:

Obese adults with a body mass index (BMI) of over 27, plus other weight-related medical problems including high blood pressure, or type 2 diabetes.

Obese adults with an initial body mass index (BMI) of over 30.

Wegovy offers obese people an alternative way to lose weight without resorting to extreme measures such as bariatric surgery.

Do you struggle with your body weight? Then perhaps the FDA approved and NICE approved new weight loss drug, Wegovy, could be the weight loss solution you’ve been looking for.

But wait, an injectable prescription medicine to help you manage your body weight? Is that even safe?

Wegovy contains the active ingredient semaglutide, which is primarily a diabetes medication. When the food and drug administration (FDA) gave this medicine the green light to treat diabetes, it soon became apparent that semaglutide containing products could also serve as a weight loss medication.

Semaglutide is a GLP-1 (glucagon-like peptide) receptor agonist that helps users control their blood sugar by imitating essential hormones. The medication restricts the release of the glucagon hormone, facilitating more insulin release, which leads to regulated blood sugar levels.

As hormones are usually responsible for controlling a person’s appetite, Wegovy can help people feel full for longer, meaning they’ll eat less and lose more weight.

While Wegovy is highly effective, you will need to reduce your food intake and increase your physical activity. However, users will be less likely to snack and fixate on food, facilitating weight loss.

However, semaglutide containing products regulate hormones, making them a more sustainable solution for effective weight loss. The beneficial new treatment option doesn’t have the horrific side effects of Orlistat, and it’s also a lot more convenient than Saxenda.

If you accidentally miss a scheduled dose and your next weekly dose is more than two days away, resume dosing as soon as possible.

If you miss a scheduled dose and the next one is less than 48 hours away, resume dosing on your regularly scheduled day.

If you miss more than two weeks’ worth of Wegovy, resume dosing on your next regularly scheduled day. If you aren’t sure, speak with your healthcare provider about how to resume dosing safely.

Wegovy had to go through numerous clinical trials before being recommended by the National Institute For Health and Care Excellence (NICE), and it will be available later this year.

During one study, the participants taking Wegovy lost around 15% of their initial body weight compared to individuals in the placebo group, which lost an average of 2.5% of their initial body mass index.

We don’t recommend patients start Wegovy on the highest dosage because your body needs time to adjust to any over-the-counter drugs.

If you don’t know if you have weight-related medical problems, taking the maximum dosage of Wegovy could see you experience a serious allergic reaction.

If you start on the highest dose of semaglutide, you risk serious hypersensitivity reactions occurring.

By starting your Wegovy weight management journey on the lowest dose, you’ll give yourself the best possible chance of weight loss success.

Because the evidence says that it works. Wegovy has been found to effectively help users lose weight when used alongside a reduced-calorie diet and increased exercise.

It can be useful if you have a BMI of 30 or above, or if you have a BMI of 28 or above alongside a weight-related health condition, like diabetes, hypertension, or high cholesterol.

Wegovy works a bit differently to other weight loss medications that function in the gut and stop you absorbing fat. Instead, it mimics a hormone that’s released after you’ve eaten, and tells the brain that you’re full. This helps with portion consumption, and helps you lose weight.

Wegovy™ is FDA-approved for weight loss at 2.5mg/week, unlike Ozempic which is only prescribed for diabetics and at a lower dose of 1mg/week. Saxenda is a similar medication but consists of liraglutide instead of semaglutide and is administered daily, unlike the weekly convenience of Wegovy™. On average, Wegovy™ patients also lose more weight with an average loss of 33 pounds over 68 weeks compared to 12 pounds with Ozempic and 18.5 pounds with Saxenda over 52 weeks.